perfluorodecalin Cas:306-94-5

We are perfluorodecalin CAS:306-94-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


perfluorodecalin

Synonyms:
OCTADECAFLUORODECALIN
Octadecafluorodecaline
perfluorodecahydronaphthalene
Naphthalene, octadecafluorodecahydro-
Perfluoro(decahydronaphthalene)
perfluorodecahydronaphthalin
1,1,2,2,3,3,4,4,4a,5,5,6,6,7,7,8,8,8a-octadecafluorodecalin
perflunafene
PP 5
PERFLUORODECALIN
PERFLUORODECALINE
Octadecafluorodecahydronaphthalene
 
Molecular Formula: C10F18
Molecular weight: 462.07800
 
Appearance and properties: transparent colorless transparent liquid
Density: 1.9
Boiling point: 142ºC
Melting point: -10ºC
Flash point: 40ºC
Refractive index: 1.3135-1.3155

 
Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.



Market News: In addition, AstraZeneca is exploring the potential of anifrolumab in a variety of diseases where type I interferon plays a key role, including lupus nephritis, cutaneous lupus erythematosus and myositis.Thalrugosaminine manufacturer.In SLE, along with the pivotal TULIP phase III programme, anifrolumab continues to be evaluated in a long-term extension phase III trial.12 A phase II trial of anifrolumab in SLE using subcutaneous delivery has been completed. 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline supplier Mindset was established in order to develop next generation pharmaceutical assets that leverage the breakthrough therapeutic potential of psychedelic drugs. ethyl 6,7-bis(cyclopropylmethoxy)-4-oxo-1H-quinoline-3-carboxylate producer

Related Products
Product Name
2-Fluoro-1,3-dimethylimidazolidinium hexafluorophosphate View Details
3,3′-Dibromo-1,1′-biphenyl View Details
2-Butyl-3-(3,5-Diiodo-4-hydroxy Benzoyl) Benzofuran Cas:1951-26-4 View Details
(2-Methoxynaphthalen-1-yl)boronic acid manufacturer photoinitiator 819 ( Cas:162881-26-7) powder manufacturer Copper indium sulfide Cas:177715-14-9 manufacturer N-(4-Cyanophenyl)guanidine manufacturer 5-(2-cyclopropyl-1-(4-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl Acetate Cas:1391194-50-5 manufacturer